Single dose of TRACER AAV vector encoding anti-HER2 antibody reduced CNS tumor burden and extended…
ADELAIDE, Australia, May 16, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO)…
Clinical trial sites open and enrolling patients in FDA and EMA registration-directed Phase III Part…
GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Hong Kong, Hong Kong–(Newsfile Corp. – May 16, 2022) – IDCM has decided to rebrand…
HONG KONG, May 16, 2022 – (ACN Newswire) – Tam Jai International Co. Limited (“TJI”…
LOS ANGELES–(BUSINESS WIRE)–Artificial Intelligence Defense Platform, a technology start-up creating AI technology for a safer,…
RONKONKOMA, N.Y.–(BUSINESS WIRE)–Noted beverage, supplement, and finance exec, and The3rdBevCo CEO Peter Scalise today announced…
New compounds specifically inhibit NLRP3 in mouse models and human cells Series includes orally active…
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Kriya Therapeutics, Inc., a fully integrated gene…
SAN FRANCISCO–(BUSINESS WIRE)–Global Retail Intelligence leader Intelligence Node announces several strategic hires to accelerate its…
JetBlue’s proposal offers Spirit’s shareholders and other stakeholders more value, more certainty and more opportunity…
TOKYO & NEW YORK–(BUSINESS WIRE)–On September 21, 2021, MUFG and MUFG Bank, a core banking…
New features and capabilities bolster Kubernetes security across the board, help apply shift-left security to…
PARIS–(BUSINESS WIRE)–Transatel – subsidiary of NTT since 2019 – announces the worldwide deployment of a…
TOKYO & NEW YORK–(BUSINESS WIRE)– Mitsubishi UFJ Financial Group, Inc. (MUFG) MUFG Bank, Ltd. MUFG…
Nuvias partners gain access to the entire Armis portfolio, addressing the considerable asset visibility market…
De nouvelles données de l’essai en ouvert PLEO-CMT-FU montrent un bénéfice durable de PXT3003 chez…
New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial,…
New Data from the Open-Label PLEO-CMT-FU Trial Shows Sustained Benefit with PXT3003 in Patients with…